Management of Insulinomas

Introduction to Insulinoma Management

The National Comprehensive Cancer Network (NCCN) guidelines recommend enucleation (local excision) as the first-line approach for exophytic or peripheral insulinomas that are not immediately adjacent to the pancreatic duct, preserving pancreatic tissue and function, due to their primarily benign nature 1, 2
Enucleation can often be performed laparoscopically, resulting in shorter hospital stays, and has acceptable morbidity and mortality rates 1

The NCCN guidelines recommend pancreatoduodenectomy (Whipple procedure) for deeper or invasive insulinomas, or those in proximity to the main pancreatic duct, or if enucleation is not technically feasible 1, 2
For insulinomas in the body/tail of the pancreas, distal pancreatectomy with or without splenectomy is recommended 2
Total pancreatectomy is not recommended as it is overly aggressive for a typically benign tumor, resulting in complete endocrine and exocrine pancreatic insufficiency 1
Laparoscopic approaches can be considered for enucleation of insulinomas in appropriate cases 1

The NCCN guidelines do not support streptozotocin administration as primary therapy for resectable insulinomas, as medical therapy is not first-line for these cases 1
The National Comprehensive Cancer Network suggests stabilizing glucose levels with diet and/or diazoxide, and using octreotide with extreme caution as it may worsen hypoglycemia 1

Preoperative localization is essential using imaging techniques, and intraoperative ultrasound is valuable for precise tumor localization and identifying relationship to the pancreatic duct 1
Lymph node assessment should be considered, as there is a small but real risk of lymph node metastases in tumors 1-2 cm in size 1

The National Comprehensive Cancer Network recommends that virtually all insulinomas should be resected regardless of size due to the metabolic complications of hypoglycemia 2, 3
Follow-up is recommended at 3-12 months after resection, then every 6-12 months for up to 10 years, with monitoring for recurrence using appropriate biochemical markers and imaging 2, 1
Insulinomas typically present with Whipple's triad: symptoms of hypoglycemia, low blood glucose, and relief of symptoms with glucose administration, and are the most common functional pancreatic neuroendocrine tumor (NET) 2